Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Epidemiological study of lung cancer in Portugal (2000/2002)].
Parente B, Queiroga H, Teixeira E, Sotto-Mayor R, Barata F, Sousa A, Melo MJ, João F, Neveda R, Cunha J, Fernandes A, Manuel M, Cardoso T, Ferreira L, Nogueira F, Duarte J, Semedo E, Brito U, Pimentel F, Barros S, Costa F, Almodôvar T, Araújo A. Parente B, et al. Among authors: barata f. Rev Port Pneumol. 2007 Mar-Apr;13(2):255-65. Rev Port Pneumol. 2007. PMID: 17571453 Portuguese.
[Cost of cancer care in Portugal].
Araújo A, Barata F, Barroso S, Cortes P, Damasceno M, Parreira A, Espírito Santo J, Teixeira E, Pereira R. Araújo A, et al. Among authors: barata f. Acta Med Port. 2009 Sep-Oct;22(5):525-36. Epub 2009 Oct 22. Acta Med Port. 2009. PMID: 19944035 Free article. Portuguese.
Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.
Araújo A, Coelho A, de Mello RA, Azevedo I, Soares M, Queiroga H, Teixeira E, Parente B, Barata F. Araújo A, et al. Among authors: barata f. Rev Port Pneumol. 2012 Sep-Oct;18(5):244-6. doi: 10.1016/j.rppneu.2012.04.011. Epub 2012 Jun 29. Rev Port Pneumol. 2012. PMID: 22748945 Free article. English, Portuguese. No abstract available.
Pemetrexed in second line treatment of non-small cell lung cancer - The portuguese experience.
Araújo A, Barata F, Parente B, Rego S, Teixeira E, Melo M, Queiroga H, Cunha J, Duarte J, Coelho A; Pelo Grupode Estudos do Cancro do Pulmão. Araújo A, et al. Among authors: barata f. Rev Port Pneumol. 2008 Jul;14 Suppl 2:S9-S20. doi: 10.1016/S0873-2159(15)30310-X. Rev Port Pneumol. 2008. PMID: 25967568 Free article. English, Portuguese.
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut.
Barata F, Queiroga H, Teixeira E, Almodovar MT, Parente B, Soares M. Barata F, et al. Rev Port Pneumol (2006). 2016 Sep-Oct;22(5):287-8. doi: 10.1016/j.rppnen.2016.03.009. Epub 2016 May 6. Rev Port Pneumol (2006). 2016. PMID: 27162148 Free article. Clinical Trial. No abstract available.
Cost and Burden of Non-Small Cell Lung Cancer's in Portugal.
Borges M, Gouveia M, Alarcão J, Sousa R, Teixeira E, Barata F, Laranjeira E, Lopes F, Parente B, Pinheiro L, Vaz-Carneiro A, Costa J. Borges M, et al. Among authors: barata f. Value Health. 2014 Nov;17(7):A626. doi: 10.1016/j.jval.2014.08.2228. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202212 Free article. No abstract available.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
69 results